Targeted radionuclide therapy for gastroenteropancreatic neuroendocrine tumors: From beta-emitters to next-generation alpha therapies. // Best Practice & Research Clinical Gastroenterology. – URL: https://www.sciencedirect.com/science/article/pii/S1521691826000284?dgcid=rss_sd_all
Targeted radionuclide therapy for gastroenteropancreatic neuroendocrine tumors: From beta-emitters to next-generation alpha therapies. Best Practice & Research Clinical Gastroenterology. https://www.sciencedirect.com/science/article/pii/S1521691826000284?dgcid=rss_sd_all
“Targeted radionuclide therapy for gastroenteropancreatic neuroendocrine tumors: From beta-emitters to next-generation alpha therapies.” Best Practice & Research Clinical Gastroenterology.
@article{article37838,
title = {Targeted radionuclide therapy for gastroenteropancreatic neuroendocrine tumors: From beta-emitters to next-generation alpha therapies},
journal = {Best Practice \& Research Clinical Gastroenterology},
url = {https://www.sciencedirect.com/science/article/pii/S1521691826000284?dgcid=rss_sd_all}
}